@inbook{67634e1d5bf1462a95d7af56d8021a2b,
title = "The management of hiv-hodgkin lymphoma",
abstract = "Hodgkin lymphoma (HL) is one of the most common non-AIDS-defining malignancies in the setting of HIV. Patients usually present with advanced-stage disease and median CD4 cell counts roughly between 150 and 250/μL. Since the introduction of combined antiretroviral therapy (cART), the prognosis of patients with HIV-HL has markedly improved. Standard curative-intent therapy and modern cART has resulted in outcomes that are similar to that reported in the general population.",
keywords = "Autologous stem cell transplantation, Brentuximab vedotin, HIV, HIV-associated Hodgkin lymphoma, Hodgkin lymphoma",
author = "Marcus Hentrich and Michele Spina",
note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2020. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
year = "2020",
doi = "10.1007/978-3-030-32482-7_19",
language = "English",
series = "Hematologic Malignancies",
publisher = "Springer",
pages = "335--347",
booktitle = "Hematologic Malignancies",
}